Core Viewpoint - Lino Pharmaceutical Packaging's stock price has declined significantly, reflecting challenges in revenue and profit, while the company is actively pursuing growth through acquisitions and joint ventures [1] Financial Performance - As of August 21, 2025, Lino Pharmaceutical Packaging's stock price is 19.86 CNY, down 1.32 CNY or 6.23% from the previous trading day [1] - In the first half of 2025, the company reported revenue of 499 million CNY, a year-on-year decrease of 11.07% [1] - The net profit attributable to shareholders was 40.97 million CNY, down 20.12% year-on-year [1] - R&D expenses increased by 7.19% to 16.03 million CNY, while sales expenses rose by 21.68% to 26.71 million CNY [1] Business Strategy - The company is expanding its business scope through acquisitions and joint ventures, aiming to establish a "glass + plastic" one-stop service capability [1] - Lino Pharmaceutical Packaging plans to jointly invest 92.65 million CNY with its controlling shareholder, Lino Group, to establish a joint venture [1] - The company intends to acquire a 30% stake in Suzhou Chuangyang New Materials Technology Co., Ltd. for 84 million CNY [1] Market Activity - On August 21, 2025, the net outflow of main funds from Lino Pharmaceutical Packaging was 59.91 million CNY, accounting for 1.26% of its market capitalization [1] - Over the past five days, the net outflow of main funds totaled 253.35 million CNY, representing 5.34% of its market capitalization [1]